Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 139 results for "claris lifesciences"

Global Respiratory Care Devices Market Forecast to 2022 - Key ...

DUBLIN--(Business Wire)--Research and Markets has announced the addition of the "Global Respiratory Care Devices Market Analysis 2016 - Forecast to 2022" report to their offering. This analysis is one of the most accurate studies performed using ... Digital Journal, 5 days ago

14 images for claris lifesciences

Moneycontrol.com, 1 month ago
Money Control, 1 month ago
Pharmaceutical Tech.com, 4 weeks ago
Business Standard India, 2 months ago
Pharmaceutical Manufacturing Magazine, 1 month ago
India Infoline, 3 months ago
India Infoline, 2 months ago
Business Standard India, 3 months ago
Sify, 2 months ago
India Infoline, 4 months ago

Global Prenatal & Maternal Diagnostic Market Worth $10.5 Billion by 2021 According to New research

Dublin, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Prenatal & Maternal Diagnostic Market Analysis to 2021" report to their offering. The global prenatal, maternal and newborn screening ...
 Benzinga.com6 days ago
Pharmaceutical Tech.com

Claris Lifesciences receives US FDA approval for flumazenil injection

The approved product, which is primarily used to help reverse anaesthesia effect, is estimated to have market size of $ 4 million in the US BS B2B Bureau | Mumbai August 30, 2016 Last Updated at 11:34 IST The Ahmedabad-based injectable major Claris ...
 Business Standard3 weeks ago Claris Lifesciences tumbles 6.2%; ges ANDA nod for Flumazenil Injection  India Infoline4 weeks ago Claris Lifesciences trades lower on receiving USFDA Form 483  Sify4 weeks ago Claris Lifesciences falls 5%; ges ANDA nod for Flumazenil Injection  India Infoline4 weeks ago
[x]  
India Infoline

Aurobindo, Claris Lifesciences and GMR Infrastructure to see some action today

India, Aug. 29 -- Home grown drug makers Aurobindo Pharma and Intas are among the final contenders for the UK and Irish portfolio of Israeli generics behemoth Teva, put up for sale to comply with European anti-trust regulations. Both players have ...
 HT Syndication4 weeks ago Stocks to be on your radar: Tata Motors, Claris, Aurobindo  Money Control4 weeks ago Top 8 stocks in focus: Lupin, Tata Power, Claris Lifesciences  India Infoline2 months ago Vedanta, Cairn India, Tata Steel, Nalco among stocks in news  Money Control1 week ago

Claris Lifesciences Slumps On US Regulator's Observations For Gujarat Facility

Claris Lifesciences shares slumped over 7 per cent on Monday after the company received five Form 483s on its Vasna, Gujarat, manufacturing facility from the US drug regulator. Form 483 is issued to a company at the conclusion of an inspection by US ...
 NDTV Profit4 weeks ago Claris Lifesciences Slumps On USFDA's Observations For Gujarat Facility  NDTV4 weeks ago

Claris Lifesciences: Outcome of board meeting

Claris Lifesciences has informed regarding Outcome of Board Meeting held on August 19, 2016.
 Money Control1 month ago Claris Lifesciences' board meeting on August 19, 2016  Moneycontrol.com1 month ago
Money Control

Claris gets mfg norm violation observations from USFDA

- Moneycontrol.com By Drug firm Claris Lifesciences today said USFDA inspectors have issued five observations highlighting violations of norms at its manufacturing facility at Chacharvadi-Vasna
 Moneycontrol.com1 month ago
Money Control

Claris Lifesciences Q1 net moves up 14% to Rs 22 cr

Drug firm Claris Lifesciences today reported a 14.3 per cent increase in its consolidated net profit at Rs 22 crore for the first quarter ended June 2016. The company has reported a net profit of Rs 19.2 crore in April-June a year ago, Claris said ...
 Business Standard1 month ago Claris Lifesciences Q1 net up 14.3% at Rs 2,200 cr  HT Syndication1 month ago

BRIEF-Claris Lifesciences June-qtr consol profit up about 14 pct

US STOCKS-Wall St inches up with energy gain, Wal-Mart * Indexes up: Dow 0.1 pct, S&P 0.2 pct, Nasdaq 0.2 pct (Updates to close) Indian shares end higher; Fed minutes dim chances of early US rate rise Aug 18 Indian shares ended higher on ...
 Reuters India1 month ago Indian shares consolidate gains; global growth uncertainty lingers  Sify2 months ago

Claris Lifesciences gains as two foreign funds mop up shares sold by a promoter group firm

Claris Lifesciences was up 4.2% at Rs 255.90 at 15:09 IST on BSE after the bulk deals data on BSE yesterday, 27 July 2016, showed that two foreign funds mopped up some of the shares of the company which were offloaded by a promoter group firm.
 Business Standard1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less